(Shared Conference with Biomarker World Congress and Digital Health Pharma Congress)

Cambridge Healthtech Institute’s 2nd Annual

Digital Biomarkers: Biosensors, Wearables, and mHealth

Clinical Utility and Emerging Applications in Drug Development

June 19-20, 2019


As the role of biosensors, wearables and mobile health in modern healthcare evolves, the potential of digital biomarkers to continually monitor patient health, rapidly diagnose disease, and accurately predict outcomes becomes increasingly apparent. Physiological data may now be collected via digital devices such as portables, wearables, and implantables. Mobile health, or “mHealth,” promises to transform not only the future of healthcare but also the process of clinical trials. CHI’s 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth conference will focus on the clinical utility of cutting-edge biosensor technology and its impact on drug development.

REAL-WORLD EVIDENCE: UTILITY OF DIGITAL BIOMARKERS

A Platform Approach to Real-World Evidence and Real-World Population Health Transformation
Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

 

Digital Biomarkers and Real-World Evidence in Clinical Research
Wasim Malik, PhD, Chief Digital Strategist, Roivant Sciences

 

Data and Metadata Standards for Real-World Digital Biomarkers

Ida Sim, MD, PhD, Co-Founder, Open mHealth; Professor, Medicine, University of California, San Francisco

 

DIGITAL BIOMARKERS AS CLINICAL ENDPOINTS

 

Challenges and Opportunities in Implementing Digital Biomarkers in Clinical Trials

Balaji Goparaju, Data Scientist, Innovative Digital Endpoints Analytics, Novartis

 

A Platform Approach to Evaluating Digital Drug Development Technologies

Joshua Cosman, PhD, Quantitative Medicine, Digital Innovation, Biogen

 

Transforming Clinical Trials with Objective, Holistic, Continuous and Ecologically Valid Digital Assessment

Jeffrey Kaye, MD, Layton Professor, Neurology & Biomedical Engineering, Director, ORCATECH - Oregon Center for Aging & Technology, Oregon Health & Science University

 

mHEALTH PLATFORMS FOR DIGITAL BIOMARKERS: MOBILE DEVICES AND APPS

Regulatory Considerations During Mobile Medical App Development

Michael J. Benecky, PhD, Senior Director, Global Regulatory Affairs, Precision and Digital Medicine, R&D Chief Regulatory Office, GlaxoSmithKline

 

The Asthma Mobile Health Study Latest Research Findings

Yu-Feng (Yvonne) Chan, MD, PhD, Associate Professor, Genetics & Genomics Sciences, Icahn School of Medicine; Director, Digital Health & Personalized Medicine, Icahn Institute for Genomics and Multiscale Biology at Mt. Sinai

 

BIOSENSORS AND WEARABLES AS NOVEL DIGITAL BIOMARKERS

Inspiration from the Unmet Patient Need and Our Long-term Vision

Gergely Vértes, MBA, Solution Accelerator Lead, Wearable for Epilepsy, UCB Pharma

 

The Verification and Use of Digital Wearable Technology to Evaluate Scratching and Sleep in Atopic Dermatitis

Carrie Northcott, PhD, Project Team Lead, Early Clinical Development, Digital Medicine, Pfizer

 

Actigraphy in Clinical Trials - Learnings and Prospects

Janet Munro, MBBS, MRC, Psych, General Manager, Digital Development, Novartis

 

Shaping the Future of Digital Health Technologies in Parkinson's Research

Lauren Bataille, MS, Senior Associate Director, Research Partnerships, Michael J. Fox Foundation

 


For more details on the conference, please contact:
Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Rod Eymael
Business Development Manager
Cambridge Healthtech Institute

781-247-6286
reymael@healthtech.com

 

Companies L-Z
Joseph Vacca, M.S.
Director, Business Development
Cambridge Healthtech Institute

781-972-5431
jvacca@healthtech.com